QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
NYSE:NOV

NOV - NOV Price Target & Analyst Ratings

$18.35
+0.56 (+3.15%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$18.19
$18.65
50-Day Range
$17.41
$24.80
52-Week Range
$13.98
$24.83
Volume
4.63 million shs
Average Volume
3.90 million shs
Market Capitalization
$7.21 billion
P/E Ratio
47.05
Dividend Yield
1.09%
Price Target
$24.75

NOV Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 15 Analyst Ratings

Consensus Analyst Price Target

$24.75
34.88% Upside
High Prediction$30.00
Average Prediction$24.75
Low Prediction$16.00
TypeCurrent
3/21/22 to 3/21/23
1 Month Ago
2/19/22 to 2/19/23
3 Months Ago
12/21/21 to 12/21/22
1 Year Ago
3/21/21 to 3/21/22
Consensus Rating
Moderate Buy
Moderate Buy
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
9 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
4 Sell rating(s)
Consensus Price Target$24.75$24.75$23.14$17.50
Predicted Upside34.88% Upside18.42% Upside16.82% Upside12.86% Upside
Get NOV Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NOV and its competitors with MarketBeat's FREE daily newsletter.

NOV Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NOV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

NOV Stock vs. The Competition

TypeNOVBusiness Services CompaniesS&P 500
Consensus Rating Score
2.53
2.55
2.47
Consensus RatingModerate BuyBuyHold
Predicted Upside34.88% Upside398.38% Upside20.88% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/8/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$22.00-6.54%
2/8/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Perform$27.00+16.03%
2/8/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$26.00 ➝ $27.00+16.03%
2/8/2023Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive$26.00 ➝ $29.00+24.62%
1/19/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$28.00+22.81%
1/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$21.00 ➝ $24.00+20.91%
12/9/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$30.00+47.71%
11/7/2022Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight$25.00+4.21%
11/7/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight$16.00 ➝ $25.00+7.67%
11/1/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$22.00 ➝ $25.00+11.61%
10/31/2022Susquehanna Bancshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$27.00 ➝ $25.00+15.85%
10/12/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$25.00+39.74%
9/30/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$19.00+20.71%
8/8/2022Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Curran
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
7/13/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSell$18.00 ➝ $16.00+6.52%
5/2/2022Griffin Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Simpson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$26.00+40.85%
4/8/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$20.00 ➝ $23.00+18.74%
2/7/2022COKER & PALMER
Subscribe to MarketBeat All Access for the recommendation accuracy rating
V. Vaishnav
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeSector Perform ➝ Sector Underperform
2/7/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Arun Jayaram
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$17.00+4.87%
7/28/2021Atb Cap Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Syed
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Outperform
7/19/2021BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform$14.00 ➝ $15.00+10.13%
1/12/2021Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
1/11/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradePeer Perform ➝ Outperform
10/28/2020Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$14.00 ➝ $15.00+74.62%
5/26/2020UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$10.00 ➝ $11.00-13.56%
4/7/2020Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Lemoine
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight
4/6/2020Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform
3/27/2020R. F. Lafferty
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$27.00 ➝ $13.00+25.24%
(Data available from 3/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












NOV Price Target - Frequently Asked Questions

What is NOV's consensus rating and price target?

According to the issued ratings of 15 analysts in the last year, the consensus rating for NOV stock is Moderate Buy based on the current 1 sell rating, 5 hold ratings and 9 buy ratings for NOV. The average twelve-month price prediction for NOV is $24.75 with a high price target of $30.00 and a low price target of $16.00. Learn more on NOV's analyst rating history.

Do Wall Street analysts like NOV more than its competitors?

Analysts like NOV less than other Business Services companies. The consensus rating for NOV is Moderate Buy while the average consensus rating for business services companies is Buy. Learn more on how NOV compares to other companies.

Is NOV being upgraded by Wall Street analysts?

Over the previous 90 days, NOV's stock had 1 upgrade by analysts.

Does NOV's stock price have much upside?

According to analysts, NOV's stock has a predicted upside of 18.42% based on their 12-month price targets.

What analysts cover NOV?

NOV has been rated by Benchmark, Cowen, Morgan Stanley, Piper Sandler, Royal Bank of Canada, and Susquehanna in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:NOV) was last updated on 3/21/2023 by MarketBeat.com Staff